Spero Therapeutics, Inc. (SPRO) Revenue 2016–2025
Spero Therapeutics, Inc. (SPRO) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$12.6MFY2025 · since FY2016: $335,000 → $12.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $12.6M | +3292.5% |
| FY2024 | $371,000 | -60.2% |
| FY2023 | $933,000 | -62.7% |
| FY2022 | $2.5M | -18.5% |
| FY2021 | $3.1M | +1089.9% |
| FY2020 | $258,000 | -94.6% |
| FY2019 | $4.7M | +19.6% |
| FY2018 | $4.0M | +100.4% |
| FY2017 | $2.0M | +490.7% |
| FY2016 | $335,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice